Objective:

To characterize the phenotype of women with Isolated Mesh Associated Pain Syndrome (I-MAPS) related to a single continence device and determine the pain mechanisms involved, specifically defining 'phenotype' for clarity.

Approach:

Key Findings:

• 280 women presented with I-MAPS over 5 years, with 52% reporting pre-existing pain conditions.
• Pain mapping indicated localized nociceptive pain and neuro-anatomically distributed neuropathic pain.
• 55% of patients had neuropathic mediated pain, 22% had nociceptive pain, and 23% exhibited mixed origin pain.
• Trans-obturator devices were associated with a higher mean PDQ score compared to retropubic devices (p = 0.04).
• Moderate impact on daily activities and moderate rates of anxiety and depression were reported, with poor physical and mental well-being scores.

Interpretation:

I-MAPS appears to be predominantly neuropathic in nature, with evidence of mixed pain origins and nociplastic features impacting quality of life. Expand on nociplastic features.

Limitations:

• Study limited to women with I-MAPS related to a single continence device, excluding those with multiple devices or other complications.
• Data collected as part of routine clinical care without formal Research Ethics Committee approval. Mention potential biases.

Conclusion:

The study highlights the multidimensional impact of I-MAPS, emphasizing the need for a better understanding of its management and implications for clinical practice.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.